COVID-19-Associated Acute Myocarditis: Risk Factors, Clinical Outcomes, and Implications for Early Detection and
Shiwani Kamath1, Mohamad-Hamood T Gomah2, Gauthier Stepman1
1Internal Medicine, Medical Center of Trinity, Trinity, USA.
Insights
Acute myocarditis is a serious complication of COVID-19, increasing the risk of ventilation and death. Routine cardiac biomarker testing and close monitoring of patients with underlying heart conditions are crucial for better outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a disease with multisystem complications, including cardiac issues.
- Acute myocarditis is a recognized complication of COVID-19, and prior research indicates higher mortality in patients with cardiac involvement.
- Understanding the impact of myocarditis and pre-existing cardiac conditions on COVID-19 outcomes is critical.
Purpose of the Study:
- To determine if COVID-19 patients develop myocarditis.
- To assess the association between myocarditis and increased need for ventilatory support and mortality.
- To evaluate if pre-existing cardiac conditions worsen outcomes in COVID-19 patients.
Main Methods:
- A multicenter, retrospective study involving 8,162 adult patients with confirmed COVID-19.
- Myocarditis was defined by elevated troponin-T (TnT) and brain natriuretic peptide (BNP) levels.
- Statistical analysis compared in-hospital mortality and ventilatory support rates between COVID-19 patients with and without myocarditis.
Main Results:
- 1,643 (20.1%) of COVID-19 patients developed new-onset acute myocarditis.
- Myocarditis significantly increased the risk of requiring ventilation and mortality (p<0.001).
- Underlying heart failure increased in-hospital mortality by 1.6 times; non-ischemic cardiomyopathy increased mortality by 2.33 times.
Conclusions:
- Myocarditis is a significant and potentially fatal complication of COVID-19.
- Routine TnT and BNP testing can help identify at-risk COVID-19 patients.
- Pre-existing heart conditions are associated with poorer COVID-19 outcomes, necessitating vigilant patient monitoring.
Abstract:
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus causing acute respiratory distress with multisystem complications, including cardiac complications. Acute myocarditis is one possible complication of coronavirus disease 2019 (COVID-19). Previous studies revealed that mortality from COVID-19 was higher in patients with cardiac complications. Objectives We aim to identify if patients with COVID-19 develop myocarditis and if this condition is associated with an increased incidence of ventilatory support and mortality. We also aim to identify if preexisting cardiac conditions are associated with an increased incidence of ventilatory support and mortality in those who developed COVID-19. Methods This is a multicenter, retrospective study including patients aged 18 years and older. Statistical analysis was performed to compare the incidence of in-hospital mortality and ventilatory support in COVID-19-positive patients with and without myocarditis. In this study, we defined myocarditis using elevated troponin-T (TnT) and brain natriuretic peptide (BNP) levels as proxy. Results A total of 8,162 patients with a positive COVID-19 polymerase chain reaction (PCR) test were identified. Of those, 1,643 (20.1%) were found to have new-onset acute myocarditis. The risk of ventilation and mortality in these patients was significantly elevated (p<0.001) compared to patients without acute myocarditis. Underlying heart failure was associated with increased odds of in-hospital mortality, which was 1.6 times greater when compared to patients without heart failure. The odds of in-hospital mortality were 2.33 times as likely for those who had non-ischemic cardiomyopathy as opposed to those who did not. Conclusion Myocarditis is a serious and potentially fatal complication of COVID-19. The results of this study highlight the importance of routine testing of troponin-T and BNP levels to identify those at risk. Furthermore, underlying heart conditions are associated with a worse outcome, and those patients should be watched closely.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis I: Introduction


